222 related articles for article (PubMed ID: 21363891)
21. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
22. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
23. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma.
Lieskovská J; Opavský R; Záciková L; Glasová M; Pastorek J; Pastoreková S
Neoplasma; 1999; 46(1):17-24. PubMed ID: 10355529
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype.
Barathova M; Takacova M; Holotnakova T; Gibadulinova A; Ohradanova A; Zatovicova M; Hulikova A; Kopacek J; Parkkila S; Supuran CT; Pastorekova S; Pastorek J
Br J Cancer; 2008 Jan; 98(1):129-36. PubMed ID: 18026188
[TBL] [Abstract][Full Text] [Related]
25. Expression pattern of carbonic anhydrase IX in Medullary thyroid carcinoma supports a role for RET-mediated activation of the HIF pathway.
Takacova M; Bullova P; Simko V; Skvarkova L; Poturnajova M; Feketeova L; Babal P; Kivela AJ; Kuopio T; Kopacek J; Pastorek J; Parkkila S; Pastorekova S
Am J Pathol; 2014 Apr; 184(4):953-965. PubMed ID: 24518567
[TBL] [Abstract][Full Text] [Related]
26. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.
Tanaka N; Kato H; Inose T; Kimura H; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Kuwano H
Br J Cancer; 2008 Nov; 99(9):1468-75. PubMed ID: 18841153
[TBL] [Abstract][Full Text] [Related]
27. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.
Wang Y; Wang XY; Subjeck JR; Kim HL
Mol Cancer Ther; 2008 Dec; 7(12):3867-77. PubMed ID: 19074859
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.
Fiaschi T; Giannoni E; Taddei ML; Cirri P; Marini A; Pintus G; Nativi C; Richichi B; Scozzafava A; Carta F; Torre E; Supuran CT; Chiarugi P
Cell Cycle; 2013 Jun; 12(11):1791-801. PubMed ID: 23656776
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinoma.
Gu MJ; Kwon KW
J Histochem Cytochem; 2014 Mar; 62(3):205-10. PubMed ID: 24217923
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
32. Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.
Guan SS; Cheng CC; Ho AS; Wang CC; Luo TY; Liao TZ; Chang J; Wu CT; Liu SH
Oncotarget; 2015 Nov; 6(34):36139-55. PubMed ID: 26447758
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.
Nasu K; Yamaguchi K; Takanashi T; Tamai K; Sato I; Ine S; Sasaki O; Satoh K; Tanaka N; Tanaka Y; Fukushima T; Harigae H; Sugamura K
Cancer Sci; 2017 Mar; 108(3):435-443. PubMed ID: 28075522
[TBL] [Abstract][Full Text] [Related]
34. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
Choi SW; Kim JY; Park JY; Cha IH; Kim J; Lee S
Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
37.
Xu J; Zhu S; Xu L; Liu X; Ding W; Wang Q; Chen Y; Deng H
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824856
[TBL] [Abstract][Full Text] [Related]
38. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7.
Huber AR; Tan D; Sun J; Dean D; Wu T; Zhou Z
BMC Gastroenterol; 2015 Jul; 15():80. PubMed ID: 26156831
[TBL] [Abstract][Full Text] [Related]
39. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
[TBL] [Abstract][Full Text] [Related]
40. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
Kim JY; Shin HJ; Kim TH; Cho KH; Shin KH; Kim BK; Roh JW; Lee S; Park SY; Hwang YJ; Han IO
J Cancer Res Clin Oncol; 2006 May; 132(5):302-8. PubMed ID: 16416108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
